28 assets in Myeloid Neoplasm

Therapeutic assets addressing Myeloid Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cytarabine Myeloid Neoplasm	First Affiliated Hospital of Zhejiang University	P3	BBB (74)
Mitoxantrone Myeloid Neoplasm	First Affiliated Hospital of Zhejiang University	P3	BBB (74)
Cladribine Myeloid Neoplasm	University of Washington	P2	BBB (72)
Cyclophosphamide Myeloid Neoplasm	Prelude Therapeutics	P3	BB (69)
Recombinant Human Granulocyte Colony-Stimulating Factor Myeloid Neoplasm	University of Washington	P2	BB (68)
Venetoclax Myeloid Neoplasm	First Affiliated Hospital of Zhejiang University	P3	BB (68)
Fludarabine Myeloid Neoplasm	First Affiliated Hospital of Zhejiang University	P3	BB (66)
Nivestim Myeloid Neoplasm	Franziska Wachter	P2	BB (66)
Methotrexate Myeloid Neoplasm	St. Jude Children's Research Hospital	P3	BB (65)
Decitabine Myeloid Neoplasm	Benjamin Tomlinson	P2	BB (64)
Melphalan Myeloid Neoplasm	First Affiliated Hospital of Zhejiang University	P3	BB (64)
Azacitidine Myeloid Neoplasm	Molecular Partners AG	P2	B (60)
Cpx-351 Myeloid Neoplasm	St. Jude Children's Research Hospital	P2	B (57)
Mesna Myeloid Neoplasm	M.D. Anderson Cancer Center	P2	B (57)
Tacrolimus Myeloid Neoplasm	M.D. Anderson Cancer Center	P2	B (57)
MP0533 Myeloid Neoplasm	Molecular Partners AG	P1/2	CCC (48)
Obinutuzumab Myeloid Neoplasm	Molecular Partners AG	P1/2	CCC (48)
Hht Myeloid Neoplasm	Ascentage Pharma Group Inc.	P1/2	CC (47)
kt-253 Myeloid Neoplasm	Kymera Therapeutics, Inc.	P1	CC (47)
Lisaftoclax Myeloid Neoplasm	Ascentage Pharma Group Inc.	P1/2	CC (47)
Olverembatinib Myeloid Neoplasm	Ascentage Pharma Group Inc.	P1/2	CC (47)
Pevonedistat Myeloid Neoplasm	M.D. Anderson Cancer Center	P1/2	CC (47)
prt2527 Myeloid Neoplasm	Prelude Therapeutics	P1	CC (47)
Zanubrutinib Myeloid Neoplasm	Prelude Therapeutics	P1	CC (47)
Glb-001 Myeloid Neoplasm	Hangzhou GluBio Pharmaceutical Co., Ltd.	P1	CC (43)
Gtb-360 Myeloid Neoplasm	Masonic Cancer Center, University of Minnesota	P1	CC (43)
Navitoclax Myeloid Neoplasm	Jacqueline Garcia, MD	P1	CC (43)
Gamma-Delta (??) T Cells Myeloid Neoplasm	Guangzhou Bio-gene Technology Co., Ltd	Early P1	C (38)